Karyotypic and molecular abnoçnfèuiitifts m chronic lymphocytic leukaemia

Journal of Clinical Pathology - Clinical Molecular Pathology

Volumn 49, Issue 4, 1996, Pages

  Fegan, C D ^a   Davies, F E ^a  

^a BIRMINGHAM HEARTLANDS HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER GENETICS; CHROMOSOME ABERRATION; CHRONIC LYMPHATIC LEUKEMIA; HUMAN; MOLECULAR BIOLOGY; PRIORITY JOURNAL; REVIEW;

EID: 0029761313     PISSN: 13552910     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (114)

1. Foon KA, Rai KR, Gale RP. Chronic lymphocytic leukaemia: new insights into biology and therapy. Ann Intern Med 1990;113:525-39.
2. Juliusson G, Oscier DG, Fitchett M, Ross FM, Stockdill G, Mackie MJ, er al. Prognostic sub-groups in B-cell chronic lymphocytic leukemia defined by specific chromosomal abnormalities. KEnglJMed 1990;323:720-4.
3. Catovsky D, Fooks J, Richards S. Prognostic factors in chronic lymphocytic leukaemia: the importance of age, sex, and response to treatment in survival. Br J Haemal ol 1989;72:141-9.
4. Han T, Ozer H, Sadamori M, Emrich L, Gomez GA, Henderson ES. Prognostic importance of cytogenetic abnormalities in patients with chronic lymphocytic leukemia. N EnglJMed 1984;310:288-92.
5. Pittman S, Catovsky D. Prognostic significance of chromosome abnormalities in chronic lymphocytic leukaemia. Br JHaematol 1984;58:649-60.
6. Juliusson G, Robert K-H, Friberg K, Biberfeld P, Nilsson B, Zech L, et al. Prognostic information from cytogenetic analysis in chronic B-lymphocytic leukaemia and leukaemic immunocytoma. Blood 1985;65:1 34-41.
7. Gahrton G, Zech L, Robert K-H, Bird AG. Cytogenetic stimulation of leukaemic cells by Epstein-Barr virus [letter]. A7EnglJMed 1979;301:438.
8. Gahrton G, Robert K-H, Friberg K, Zech L, Bird AG. Non random chromosomal abberrations in chronic lymphocytic leukaemia revealed by polyclonal B-cell mitogen stimulation. Blood 1980;56:640-7.
9. Robert K-H, Moller E, Gahrton G, Eriksson H, Nilsson B. B-cell activation of peripheral blood lymphocytes from patients with chronic lymphocytic leukaemia. Clin Exp Immunol 1978;33:302-8
10. Juliusson G, Oscier D, Gahrton G. Cytogenetic findings and survival in B-cell chronic lymphocytic leukaemia. Second IWC CLL compilation of data on 662 patients. Lenk Lvmphoma 1991;(Suppl l):21-5.
11. Juliusson G, Gahrton G. Cytogenetics in CLL and related disorders. Baillieres Clin Haemawl 1993;6:821-48.
12. Gaidano G, Newcomb EW, Gong JZ, Tassi V, Neri A, Cortelezzi A, et al. Analysis of alterations of oncogenes and tumour suppressor genes in chronic lymphocytic leukemia. AmJPathol 1994;144:1312-19.
13. Philip P, Geisler C, Hansen MM, Hasselbalch H, Christensen BE, Drivsholm A, et al. Aberration of chromosome 6 in 193 newly diagnosed untreated cases of chronic lymphocytic leukemia. Cancer Genet Cytogenet 1991;53:35-43.
14. Oscier DG, Stevens J, Hamblin DJ, Pickering RM, Lambert R, Fitchett M. Correlation of chromosome abnormalities with laboratory features and clinical cause in B-cell chronic lymphocytic leukaemia. Br J Haemawl 1990; 76:352-8."
15. Richardson ME, Quanguang C, Philippa DA, Offit K, Hampton A, Koduru PRK, et al. Intermediate to high-grade histology of lymphomas carrying t(14;18) is associated with additional non-random chromosome changes. Blood 1987;70:444-7.
16. Armitage JO, Sange WG, Weisenburger DD, Harrington DS, Linder J, Bierman PJ, et al. Correlation of secondary cytogenetic abnormalities with histological appearance in non-Hodgkin's lymphoma bearing t(14; 18)(q32;q21). J Xatl Cancer Inst 1988;80:576-80.
17. Pittman S, Catovsky D. Chromosome abnormalities in B-cell prolymphocytic leukemia: a study of nine cases. Cancer Genet Cytogenet 1983;9:355-65.
18. Offit K, Parsa NZ, Gaidano G, Filippa DA, Louie D, Pan D, et al. 6q deletions define distinct clinico-pathologic sub sets of non-Hodgkin's lymphoma. Blood 1993;82:215762.
19. Offit K, Louie DC, Parsa NZ, Filippa D, Gangi M, Sieben R, et al. Clinical and morphologic features of B-cell small lymphocytic lymphoma with del(6)(q21;q23). Blood 1994; 83:2611-18.
20. Brito-Babapulle V, Ellis J, Matures E, Oscier D, Khokha K, MacLennan K, et al. Translocation t(l I;14)(ql3;q32) in lymphoid leukaemias of B-cell type [abstract]. Blood 1991; 78(Suppl l):32a.
21. Van den Berge E, De Wolf PC, Wlodarska I, Stul N, Louwagie A, et al. Chromosome llq re-arrangement in B-non Hodgkin's lymphoma. BrJHaematol 1992;81:21217.
22. Cuneo A, Balboni M, Piva M, Rigolin GM, Roberti MG, Mejak C, et al. Atypical chronic lymphocytic leukaemia with t(l I;14)(ql3;q32): karyotype evolution and prolymphocytic transformation. Br J Haematol 1995;90:409-16.
23. Newman RA, Peterson B, Davey FR, Brabyn C, Collins H, Brunette V L, et al. Phenotypic markers and BCL-1 gene rearrangement in B-cell chronic lymphocytic leukaemia: a Cancer Leukaemic Group B Study. Blood 1993;82:123946.
24. de Boer CJ, Schuuring E, Dreef E, Peters G, Bartek J, Kluin PM, et al. Cyclin Dl protein analysis in the diagnosis of mantle cell lymphoma. Blood 1995;86:2715-23.
25. Rimokh R, Berger F, Bastard C, Klein B, French M, Archimbaud E, et al. Rearrangement of CCND1 (BCL-1/ PRAD-1)3' untranslated region in mantle-cell lymphomas and t(l Iql3)-associated leukaemias. Blood 1994;83:3689-96.
26. Raffeld M, Jaffe E S. BCL-1, t(ll;14), and mantle cell-derived lymphomas. Blood 1991;78:259-63.
27. Raghoebier S, van Krieken JHJM, Kluin-Nelenans JC, Gillis A, van Ommen GJB, Ginsberg AM, et al. Oncogene rearrangement in chronic B-cell leukaemia. Blood 1991; 77:1560-4.
28. Meeker TC, Grimaldi JC, O'Rourke R, Louie E, Juliusson G, Einhorn S. An additional break point region in the BCL-1 locus associated with the t(ll; 14) (q!3;q32) translocation of B-lymphocytic malignancy. Blood 1989; 74:1801-6.
29. Oscier DG. Cytogenetic and molecular abnormalities in chronic lymphocytic leukaemia. Blood Reviews 1994;8:88-97.
30. Bird ML, Ueshima Y, Rowley JD, Haren JM, Vardiman JW. Chromosome abnormalities in B-cell chronic lymphocytic leukemia and their clinical correlations. Leukemia 1989; 3:182-91.
31. Nowell PC, Moreau L, Growney P, Besä EC. Karyotypic stability in chronic B-cell leukemia. Cancer Genet Cytogenet 1988;33:155-60.
32. Hernandez JM, Mecucci C, Criel A, Meeus P, Michaux L, Louwagie A, et al. Cytogenetic result in 467 cases of B-cell chronic lymphoid leukaemias classified according to morphologic and immunophenotypic (FAB) criteria [abstract]. Blood 1994;84(Suppl l):454a.
33. Dohner H, Stilgenbauer S, Liebish P, Benner A, Schröder M, Weilguni T, et al. llq deletions of a second most common chromosome aberration in B-cell chronic lymphocytic leukaemia and are associated with advanced stages and marked lymphadenopathy [abstract]. Blood 1995; 86(Suppl l):345a.
34. Fegan C, Robinson H, Thompson P, Whittaker JA, White D. Karyotypic evolution in CLL: identification of a new sub-group of patients with deletions of 1 Iq and advanced or progressive disease. Leukemia 1995;9:2003-8.
35. Stilgenbauer S, James MR, Liebisch P, Schröder M, Weilguni T, Bentz M, et al. Aberrations of chromosome 11 between chronic lymphoid neoplasms characterised by FISH [abstract]. Blood 1995;86(Suppl l):168a.
36. Padua RA, McKenna S, Butler PC, Williams-Gregory D, Jordan D, Smith M, et al. Identification of a retino-acid receptor a (RARa) gene rearrangements in leukaemias: cloning of a novel RARa-PLZF (promyelocytic leukaemias in zinc finger) fusion in a patient with chronic lymphocytic leukaemia [abstract]. Blood 1995;826(Suppl l):34a.
37. Crossen PE, Horn HL. Origin of trisomy 12 in B-cell chronic lymphocytic leukemia. Cancer Genet Cytogenet 1987;28:185-6.
38. Mecucci C, Delannoy A, van den Berge H. The origin of trisomy 12 in B-cell chronic lymphocytic leukemia. Cancer Genet Cytogenet 1988;36:203-4.
39. Losada AP, Wessman M, Tiainen M, Hopman AHN, Willard HF, Sole F, et al. Trisomy 12 in chronic lymphocytic leukaemia: an interface Cytogenetic study. B/oorfl991;78;775-97.
40. Anastasi J, Le Beau MM, Vardiman JW, Fernald AA, Larson RA, Rowley JD. Detection of trisomy 12 in chronic lymphocytic leukaemia by in-situ hybridisation to interface cells: a simple and sensitive method. Blood 1992; 79:1796-801.
41. Bienz N, Cardy DLN, Leyland MJ, Hulten MA. Trisomy 12 in B-cell chronic lymphocytic leukaemia: an evaluation of 33 patients by direct fluorescence in-situ hybridisation (FISH). BrJHaematol 1993;85:819-22.
42. Knuutila S, Elonen E, Teerenhovi L, Rossi L, Leskinen R, Bloomfield CD, et al. Trisomy 12 in B-cells of patients with B-cell chronic lymphocytic leukaemia. N Engl J Med 1986;314:865-9.
43. Que TH, Garcia-Marco J, Ellis J, Matutes E, BritoBabapulle V, Boyle S, et al. Trisomy 12 in chronic lymphocytic leukaemia detected by fluorescence in-situ hybridisation: analysis by stage immunophenotype and morphology. toorf!993;82:571-5.
44. Criel A, Wlodarsta I, Meeus P, Stule M, Louwagie A, van Hoof A, et al. Trisomy 12 is uncommon in typical chronic lymphocytic leukaemia. Br J Haematol 1994;87:523-8.
45. Matutes E, Oscier D, Garcia-Marco J, Ellis A, Copplestone R, Gillingham T, et al. Trisomy 12 defines a group of CLL with atypical morphology: correlation between cytogenetic, clinical and laboratory features in 544 patients. Br J Haematol 1996;92:382-8.
46. Witzig TE, Borell TJ, Herath JF, Tefferi A, Li C-Y, Jenkins RB. Detection of trisomy 12 by FISH in untreated B-chronic lymphocytic leukaemia: correlation with stage and CD20 antigen expression intensity. Leuk Lymphoma 1994;14:447-51.
47. Oscier D, Fitchett M, Herbert T, Lambert R. Karyotypic evolution in B-cell chronic lyphocytic leukaemia. Genes Chromosom Cancer 1991;3:16-20.
48. Garcia-Marco J, Metutes E, Morilla R, Ellis J, Oscier D, Fantes J, et al. Trisomy 12 in B-cell chronic lymphocytic leukaemia: assessment of lineage restriction by simultaneous analysis of immunophenotype and genotype in interphase cells by fluorescence in-situ hybridisation. Br J Haematol 1994;87:44-50.
49. Jabbar SAB, Ganeshaguiu K, Wickremasinghe RG, Hoffbrand AV, Foroni L. Deletion of chromosome 13 (band q!4) but not trisomy 12 is a clonal event in B-cell chronic lymphocytic leukaemia (CLL). Br J Haematol 1995; 90:476-8.
50. Han T, Ohtaki K, Sadamori N Block W, Dadey B, Ozer H, et al. Cytogenetics evidence for clonal evolution in B-cell chronic lymphocytic leukemia. Cancer Genet Cytogenet 1986;23: 321-8.
51. Juliusson G, Frieberg K, Gahrton G. Consistency of chromosomal aberrations and chronic B-lymphocytic leukaemia. Cancer 1988;62:500-6.
52. Garcia-Marco J, Jones D, Colman S, Matutes E, Oscier D, Catovsky D, et al. Lineage restriction of trisomy 12 and RB 1 deletions in chronic lymphocytic leukaemia (CLL) by combined immunophenotyping and dual colour interphase FISH [abstract]. Blood 1995;86(Suppl l):344a.
53. Butturini A, Gale RP. Oncogenes in chronic lymphocytic leukaemia. Leuk Res 1988;12:89-92.
54. Momand J, Zambetti GP, Olson DC, George D, Levine AJ. The MDM-2 oncogene product forms a complex with the P53 protein and inhibits P53-mediated transactivation. Cell 1992;69:1237-45.
55. Oliner JD, Kinzler KW, Neltzer PS, George DL, Vogelstein B. Amplification of a gene encoding a P53-associated protein in human sarcoma. Nature 1992;358:80-3.
56. Ridge SA, Dyer M, Greaves MF, Wiedemann LM. Lack of MDM-2 amplification in human leukaemia. Br J Haematol 1994;86:407-9.
57. Bueso-Ramos CE, Manshouri T, Haidar MA, Huhn YO, Keating MJ, Albitar M. Multiple patterns of MDM-2 deregulation in human leukaemias: implication and leukaemic genesis and prognosis. Leuk Lymphoma 1995; 17:13-18.
58. Watanabe T, Hotta T, Ichikawa A, Kinoshita T, Nagai H, Uchida T, et al. The MDM 2 oncogene over expression in chronic lymphocytic leukaemia and low grade lymphoma of B-cell ongin. Blood 1994;84:3158-65.
59. Daeninck PJ, Begleiter A, Verbürg L, Lee K, Williams G, Israels LG, et al. Correlation of BAX, BCL-2 and MDM-2 expression with drug sensitivity in chronic lymphocytic leukaemia (CLL) [abstract]. Blood 1995;86(Suppl l):345a.
60. Fitchett M, Griffiths MJ, Oscier DJ, Johnson S. Seabright chromosome abnormalities involving 13ql4 hématologie malignancies. Cancer Genet Cytogenet 1987;24:143-50.
61. Peterson LC, Lindquist LL, Church S, Kaye NE. Frequent clonal abnormalities of chromosome band 13ql4 in B-cell chronic lymphocytic leukemia: multiple clones, sub-clones and non-clonal alterations in 82 mid-Western patients. Genes Chromosom Cancer 1992;4:273-8.
62. Kay NE, Ranheim EA, Peterson LC. Tumour suppressor genes and clonal evolution in B-CLL. Leuk Lymphoma 1995;18:41-9.
63. Peterson L, Blackstadt M, Kay N. Clonal evolution in 'chronic lymphocytic leukaemia. In. Cheson BD, ed. Chronic lymphocytic leukemia. New York: Dekker, 1993:181-96.
64. Heim S, Mitelman F. Cytogenetically unrelated clones in hématologie neoplasms. Leukemia 1989;3:6-8.
65. Kay NE, Suen R, Ranheim E, Peterson LC. Confirmation of RB gene defect in B-CLL clones and evidence for variable predominance of the Rb defective cells within the CLL clone. Br J Haematol 1993;84:257-64.
66. Brown AG, Ross FM, Dünne EM, Steel CM, WeirThompson EN. Evidence for a new tumour suppressor locus (DBN) in human B-cell neoplasia telomeric retinoblastoma gene. Nature Genet 1993;3:67-72.
67. Liu Y, Grander D, Soderhall S, Juliusson G, Gahrton G, Einhorn S. Retinoblastoma gene deletions in B-cell chronic lymphocytic leukaemia. Genes Chromosom Cancer 1992;4:250-6.
68. Stilgenbauer S, Dohner H, Bulgay-Morschel M, Weitz S, Bentz M, Lieter P. High frequency of monoallelic retinoblastoma gene deletion in B-cell chronic lymphocytic leukaemia shown by interface cytogenetics. Blood 1993;81:2118-24.
69. del Giglio A, O'Brien S, Deisseroth AB. Retinoblastoma protein expression is frequently altered in chronic lymphocytic leukaemia. Cancer Res 1994;54:242-6.
70. Ginsberg AM, Raffeld M, Cossman J. Inactivation of the retinoblastoma gene in human lymphoid neoplasms. Blood 1991;77:833-40.
71. Neubauer A, De Cant E, Rochlitz C, Laser J, Zanetta AN, Gallardo J, et al. Altered expression of the retinoblastoma susceptibility gene in chronic lymphocytic leukaemia. BrJ Haematol 1993;85:498-503.
72. Liu Y, Szekely L, Grander D, Zoderhall S, Juliusson G, Gahrton G, et al. Lymphocytic leukaemia cells with allelic deletions at 13ql4 commonly have one intact RB-1 gene: evidence for role of an adjacent locus. Proc Nat! Acad Set USA 1993;90:8697-70!.
73. Juliusson G, Gahrton G, Einhorn S, Liu Y, Oscier DG, Chapman R. Chromosome abnormalities and RB 1 gene deletion in chronic lymphocytic leukaemia. Blood 1993; 82:1938-9.
74. Neubauer A, Richiero K, Huhn D. Alterations of retinoblastoma susceptibility gene in chronic lymphocytic leukaemia. Leuk Lymphoma 1995;18:399-404.
75. Hawthorn LA, Chapman R, Oscier D, Cowell JK. The consistent 13ql4 translocation break point seen in chronic B-cell leukaemia (BCLL) involved deletions of the D13S25 locus which lies distal to the retinoblastoma predisposition gene. Oncogene 1993;8:1415-19.
76. Chapman RM, Corcorna MM, Gardiner A, Hawthorn LA, Cogwell JK, Oscier DG. Frequent homozygous deletions of the D13 S25 locus in chromosome region 13ql4 defines the location critical gene in leukemogenesis in chronic B-cell lymphocytic leukaemia. Oncogene 1994;9:1289-93.
77. Ganeshagui K, Jabbar SAB, Hoffbrand AV, Foroni L. Molecular investigation of chromosome 13ql4 abnormalities in chronic lymphocytic leukaemia [abstract]. Blood 1995;86(Suppl l):608a.
78. Stilgenbauer S, Leupolt E, Ohl S, Weib G, Schröder M, Fischer K, et al. Heterogeneity of deletions involving RB-1 and the D13S25 locus in B-CLL revealed by FISH. Blood 1995;86 (Suppl l):743a,
79. Liu Y, Hermanson M, Grander D, Merup M, Wu X, Heyman M, et al. 13q deletions in lymphoid malignancies. fooJ1995;86:1911-15.
80. Jonneaux P, Hillion J, Bennaceur AL, D'Agay MF, Brice P, Daniel MT, et al. t(14;18) and Bcl-2 gene rearrangements in a B-chronic lymphocytic leukaemia. Br J Haematol 1992;81:620-1.
81. Cleary ML, Sklar J. Nucleotide sequence of a t( 14; 18) chromosomal break-point in follicular lymphoma and demonstration of a break-point-clustering region near a transcriptionally active locus on chromosome 18. Proc Katl Acad Sei USA 1985;82:7439-43.
82. Cleary ML, Galili M, Sklar J. Detection of a second t( 14; 18) break-point clustering region in follicular lymphomas. J ExpAïed 1986;164:315-20.
83. Dyer MJS, Zani VJ, Lu WZ, O'Byrne A, Mould S, Chapman R, et al. Bcl-2 translocations in leukaemias of mature B-cells. Blood 1994;83:3682-8.
84. Lane DP, Crawford LV. T antigen is bound to a host protein in SV40-transformed cells. Nature 1979;278:261-3.
85. Levine AJ, Momand J, Finlay CA. The p53 tumour suppressor gene. Nature 1991;351:453-6.
86. Caron de Fromentel C, Soussi T. p53 tumour suppressor gene: a model for investigating human mutagenesis. Genes Chromosom Cancer 1992;4:1-15.
87. Lane DP, Benchimol S. p53: oncongene or antioncogene. Genes DER 1990;4:1.
88. Vogelstein B, Kinzlei KW. p53 Function and dysfunction. Ce//1992;70:523-6.
89. Lane DP. p53, guardian of the genome. !\'atnre 1992; 358:15-16.
90. Gaidano G, Ballerini P, Gong JZ, Inghirami G, Neri A, Newcomb EW, et al. p53 mutations in human lymphoid malignancies: association with Burkitt lymphoma and chronic lymphocytic leukemia. Proc Kail Acad Sei USA 1991;88:5413-17.
91. Gandini D, Aguiari GL, Cuneo A, Piva R, Castoldi GL, Del Senno L. Novel small deletions of the p53 gene in late-stage B-cell chronic lymphocytic leukaemia. Br J Haematol l994$&:881-5.
92. Fenaux P, Preudhomme C, Lai JL, Quiquandon I, Jonveaux P, Vanrumbeke M, et al. Mutations of the p53 gene in B-cell chronic lymphocytic leukemia: a report of 39 cases with cytogenetic analysis. Leukemia 1992;6:246-50.
93. El Rouby S, Bayona W, Pisharody SM, Newcomb EW. p53 mutations in B-cell chronic lymphocytic leukaemia. Citrr Top Microbiol Immunol 1992;184:313-17.
94. El Rouby S, Thomas A, Costin D, Rosenberg CR, Potmesil M, Silber R, et al. p53 gene mutation in B-cell chronic lymphocytic luekaemia is associated with drug resistance and is independent of MDR-l/MDR-3 gene expression. /oorf!993;82:3452-9.
95. Wattel E, Preudhomme C, Hecquet B, Vanrumbeke M, Quesnel B, Dervite I, et al. p53 mutations are associated with resistance to chemotherapy and short survival in haematologic malignancies. Blood 1994;84:3148-57.
96. Matolcsy A, Inghirami G, Knowles DM. Molecular genetic demonstration of a diverse evolution of Richter's syndrome (chronic lymphocytic leukaemia and subsequent large cell lymphoma). Blood 1994;83:1363-7.
97. Dohner H, Fischer K, Stilgenbauer S, Bentz M, Hansen K Weiss G, er al. p53 gene deletion predicts a poor survival and non-response to treatment with purine analogues in chronic B-cell leukaemias [abstract]. Blood 1994; 84(Suppl l):439a.
98. Lowe SW, Ruley HE, Jacks T, Houseman DE. p53dependent apoptosis modulate for cytotoxicity of anticancer agents. Cell 1993;74:957-67.
99. Cuneo A, De Angeli C, Robeni MG, Piva N, Bigoni R, Gandini D, el al. Richter's syndrome in a case of atypical chronic lymphocytic leukaemia with t(ll;14) (q!3;q32): role for a p53 exon 7 gene mutation. Br J Haematol 1996; 92:375-81.
100. Rechavi G, Katzir N, Brok-Simoni F, Holtzman F, Mandel M, Gurfmkel N, et al. A search for BCL-1, BCL-2 and C-MYC oncongene rearrangements in chronc lymphocytic leukemia. Leukemia 1989;3:57-60.
101. Tashiro S, Takechi M, Azou H, Takauchi K, Kyo T, Dohy H, et al. Cytogenetic 2; 18 and 18;22 translocation in chronic lymphocytic leukaemia with juxtaposition of BCL-2 and immunoglobulin light chain genes. Oncogene 1992;7:573-7.
102. Adachi M, Tsujimoto Y. Juxtaposition of human BCL-2 and immunoglobulin lambda light chain gene in chronic lymphocytic leukemia is the result of a reciprocal chromosome translocation between chromosome 18 and 22. Oncogene 1989;4:1073-5.
103. Adachi M, TefTeri A, Greipp PR, Kipps TJ, Tsujimoto Y. Preferential linkage of BCL-2 to immunoglobulin light chain gene in chronic lymphocytic leukaemia. J Exp Med 1990;171:559-64.
104. Adachi M, Cossman J, Longo D, Croce CM, Tsujimoto Y Variant translocation of BCL-2 gene to immunoglobulin lambda light chain gene in chronic lymphocytic leukaemia. Proc KatlAcadSd USA 1989;86:~2771-4:
105. Hanada M, Delia D, Aiello A, Stadtmauer E, Reed JC. BCL-2 gene hypomethylation and high level expression in B-cell chronic lymphocytic leukaemia. Blood 1993; 82:1820-8.
106. Schena M, Larsson L-G, Gottardi D, Gaidan G, Carlsson N, Nilsson K, et al. Growth and differentiation associated expression of BCL-2 in B-chronic lymphocytic leukaemia cells. /oorfl992;79:2981-9.
107. Mariano MT, Moretti L, Donelli A, Grantini M, Montagnani G, Di Frisco AU, et al. BCL-2 gene expression in haemopoietic cell differentiation. Blood 1992;80:768-75.
108. Bennett JM, Catovsky D, Daniel M-T, Flandrin G, Gallon DAG, Gralnick HR, et al. Proposals for the classification of chronic (mature) B and T lymphoid leukaemias. J Clin Palhol 1989;42:567-84.
109. Matutes E, Owusu-ankomah K, Morilla R, Garcia Marco J, Houlihan A, Que TH, et al. The immunological profile of B-cell disorders and proposal of a scoring system for diagnosis of CLL. Leukemia 1994;8:1640-5.
110. Hernandez JN, Mecucci C, Criel A, Meeus P, Michaux L, Van Hoof A, et al. Cytogenetic analysis of B-cell chronic lyrnphoid leukemias classified according to morphologic and immunophenotypic (FAB) criteria. Leukemia 1995; 9:2140-6.
111. Young BD. Cytogenetic and molecular analysis of chromosome Ilq23 abnormalities in leukaemia. Baillière's Clin Haematol 1992;5:881-95.
112. Jewell AP, Worman CP, Lydyard PM, Yong KL, Giles FJ, Goldstone AH. Interferon-alpha up-regulates be 1-2 expression and protects B-CLL from apoptosis in vitro and in vivo. Br J Haematol 1994;88:268-74.
113. Buschle M, Campana D, Carding SR, Richard C, Hoffbrand AV, Brenner MK. Interferon y inhibits apoptotic cell death in B cell chronic lymphocytic leukaemia. J Exp Med 1993;!77: 213-18.
114. Danescu M, Rubio-Trujillo M, Biron G, Bron D, Delespesse G, Sarfati M. Interleukin-4 protects chronic lymphocytic leukaemic B cells from death by apoptosis and up-regulates be 1 -2 expression. J Exp Med 1992; 176:131926.